• PRMT5-Driven Splicing and Metabolic Vulnerability

  2026-08-14

  The reference study shows that MYCN-amplified neuroblastoma is highly dependent on PRMT5-regulated splicing, epitranscriptomic control, and glutamine metabolism. Its integrated use of transcriptomics, isotope tracing, molecular validation, and mouse models identifies a mechanistic route from PRMT5 inhibition to GLS protein loss and metabolic stress.

• BRD4–RAC1 Co-targeting Rewires Breast Cancer Signaling

  2026-08-14

  The 2021 reference study identifies combined BRD4 and RAC1 inhibition as a context-dependent strategy that suppresses breast cancer growth, migration, stemness, and tumorigenesis across molecular subtypes. Its mechanistic contribution is the connection of BRD4–RAC1 blockade to disruption of the c-MYC–G9a–FTH1 axis and reduction of HDAC1-associated chromatin signaling.

• SB 431542: ALK5 Inhibitor Workflow Guide

  2026-08-13

  SB 431542 provides a practical way to separate ALK5-dependent TGF-β responses from downstream changes in proliferation, motility, immune behavior, and neuroinflammation models. This workflow connects validated Smad2 pathway assays with hypothesis-driven studies inspired by recent Alzheimer’s disease research.

• PR-619 for DUB and Ubiquitination Research

  2026-08-13

  PR-619 is a reversible, cell-permeable DUB inhibitor that accumulates ubiquitinated proteins without directly blocking proteasomal catalytic activity. This article translates that distinction into practical workflows for cancer biology research, autophagy activation assays, neurodegenerative disease models, and hypothesis-driven immuno-oncology studies.

• GGFG Peptide: From Epigenetic Insight to Conjugate Design

  2026-08-12

  A translational framework for using Gly-Gly-Phe-Gly as a flexible linker in drug conjugation research, informed by mechanistic findings in MLL-rearranged leukemia and grounded in experimentally testable design principles.

• ZCL278: A Mechanism-First Cdc42 Assay Guide

  2026-08-12

  ZCL278 is a selective Cdc42 inhibitor for connecting biochemical activity with cell migration, neuronal morphology, and fibrosis-related signaling. This mechanism-first guide explains how the kidney fibrosis literature can sharpen assay design without overstating what the compound has demonstrated.

• WST-8 Glucose Uptake Assay Kit: Practical Guide

  2026-08-11

  A scenario-based guide to using the WST-8 Glucose Uptake Assay Kit, SKU K2303, for quantitative, non-radioactive cellular glucose uptake studies. It covers assay principles, controls, protocol parameters, interpretation, and practical product-selection criteria for metabolic, diabetes, and cancer research.

• Stat3 and NF-κB in Fyn-Driven Neurodegeneration

  2026-08-10

  This study develops a neural-specific zebrafish model showing that constitutively active Fyn drives dopaminergic neuron loss, mitochondrial abnormalities, and microglial inflammation. Transcriptomic and chemical inhibition experiments identify Stat3 as a downstream effector that acts synergistically with NF-κB, providing a mechanistic framework for studying Fyn-associated neurodegeneration.

• Biotin Azide for Mechanistic Wnt Assays

  2026-08-09

  Biotin Azide connects selective click labeling with mechanistic studies of Fzd5, cholesterol, and Wnt/β-catenin signaling. This guide explains how to design controls, choose assay formats, and interpret affinity-based evidence without overstating what the underlying cancer study demonstrated.

• Nadolol (SQ-11725): Designing Better PK Assays

  2026-08-08

  Nadolol (SQ-11725) offers a practical model for connecting beta-adrenergic pharmacology with transporter-aware pharmacokinetic analysis. This article applies disease-state and tissue-distribution insights from recent research to improve hypertension research, angina pectoris studies, and vascular headache research workflows.

• CRC Prognostic Biomarkers: TIMP1 and a Five-Gene Model

  2026-08-07

  Huang et al. integrated public transcriptomic datasets, network analysis, and Cox-based modeling to develop a five-gene colorectal cancer prognostic signature containing TIMP1, PCOLCE2, MEIS2, HDC, and CXCL13. External validation and siRNA experiments further prioritized TIMP1 as a candidate biomarker, although prospective clinical testing and deeper mechanistic studies are still needed.

• Strategic MMP Inhibition: GM 6001 (Galardin) in Translationa

  2026-08-07

  This thought-leadership article explores the transformative potential of GM 6001 (Galardin) as a broad spectrum matrix metalloproteinase inhibitor across neurodegeneration, tissue remodeling, and translational models. Integrating mechanistic insight, experimental validation, and strategic guidance, it highlights the pivotal role of MMP inhibition in preserving extracellular matrix integrity, with actionable advice for researchers navigating preclinical and translational challenges.

• Mouse Tissue Lysis Kit (K1038): Protocol and Best Practices

  2026-08-06

  The Mouse Tissue Lysis Kit (K1038) streamlines sample preparation for direct genotyping assays by enabling rapid lysis of mouse tissues and eliminating the need for conventional DNA extraction. It is intended for molecular biology research but should not be used for diagnostic or clinical purposes.

• BMX-IN-1: Unraveling BMX Kinase’s Role in Host-Pathogen and

  2026-08-06

  Explore the advanced applications of BMX-IN-1, a selective BMX kinase inhibitor, in dissecting cell signaling crucial for cancer and infectious disease research. This article uniquely connects BMX-IN-1’s mechanistic impact to emerging host-pathogen insights and optimized assay design.

• HyperScript III RT SuperMix: Precision qPCR for CRC Biomarke

  2026-08-05

  HyperScript III RT SuperMix for qPCR (with gDNA wiper) enables ultra-sensitive, high-fidelity detection of critical colorectal cancer biomarkers, even from low-input or high-GC content RNA. Its robust genomic DNA removal and optimized primer system empower researchers to confidently profile gene expression in complex, heterogeneous tumor samples.

452 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page